Career history of Graeme Roy Kaufman
Former positions of Graeme Roy Kaufman
| Companies | Position | Start | End |
|---|---|---|---|
| PARADIGM BIOPHARMACEUTICALS LIMITED | Chairman | 2014-05-01 | 2020-06-23 |
| IDT AUSTRALIA LIMITED | Director/Board Member | 2017-11-20 | 2019-11-17 |
| Chairman | 2013-10-02 | 2017-11-20 | |
| Independent Dir/Board Member | 2013-05-31 | 2017-11-20 | |
| BIONOMICS LIMITED | Director/Board Member | 2012-09-17 | 2012-12-30 |
| Chairman | 2012-12-30 | 2016-11-07 | |
| Independent Dir/Board Member | 2012-09-17 | 2016-11-07 | |
| ANAGENICS LIMITED | Director/Board Member | 2012-08-27 | 2015-06-29 |
| Independent Dir/Board Member | 2012-08-26 | 2015-06-29 | |
| MESOBLAST LIMITED | Corporate Officer/Principal | - | 2012-12-31 |
| OPTHEA LIMITED | Director/Board Member | 2002-01-29 | 2007-10-24 |
| CSL LIMITED | Director of Finance/CFO | 1983-12-31 | 1998-12-31 |
| ZENYTH THERAPEUTICS LIMITED | Director/Board Member | - | - |
Training of Graeme Roy Kaufman
| University of Melbourne | Masters Business Admin |
Statistics
International
| Australia | 10 |
Operational
| Director/Board Member | 5 |
| Independent Dir/Board Member | 3 |
| Chairman | 3 |
Sectoral
| Health Technology | 8 |
| Consumer Non-Durables | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 7 |
|---|---|
| OPTHEA LIMITED | Health Technology |
| CSL LIMITED | Health Technology |
| ANAGENICS LIMITED | Consumer Non-Durables |
| BIONOMICS LIMITED | Health Technology |
| IDT AUSTRALIA LIMITED | Health Technology |
| PARADIGM BIOPHARMACEUTICALS LIMITED | Health Technology |
| MESOBLAST LIMITED | Health Technology |
| Private companies | 1 |
|---|---|
CSL Innovation Pty Ltd.
 CSL Innovation Pty Ltd. Pharmaceuticals: MajorHealth Technology CSL Innovation Pty Ltd. develops pharmaceutical products. The firm also develops human antibody inhibitors of the granulocyte-macrophage colony stimulating factor receptor alpha subunit, GM-CSFRa, for potential therapeutic use in inflammatory diseases. The company was founded in 1986 and is headquartered in Richmond, Australia. | Health Technology |
- Stock Market
- Insiders
- Graeme Roy Kaufman
- Experience
